STAT

He can shame Pfizer and others, but Trump doesn’t have a practical way to lower drug prices

Trump can threaten all he wants. But his ranting reveals an inability to accept that delivering on his promise will be much harder than he realized.
Source: Chip Somodevilla/Getty Images

Even in the boardrooms of Pfizer, they had to have expected President Trump’s Twitter outburst on Monday. If anything, the Pfizer executives set themselves up to be a target.

Let’s look back to the end of May, when Trump promised that some big drug makers would take “voluntary, massive” price cuts in two weeks.

Well, it’s been close to six weeks and, so far, most large brand-name drug makers , although few companies raised prices by any meaningful amount, either. This is a time of year,

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks